Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2

被引:81
|
作者
Sapkal, Gajanan N. [1 ]
Yadav, Pragya D. [1 ]
Ella, Raches [2 ]
Deshpande, Gururaj R. [1 ]
Sahay, Rima R. [1 ]
Gupta, Nivedita [3 ]
Vadrevu, Krishna Mohan [2 ]
Abraham, Priya [1 ]
Panda, Samiran [3 ]
Bhargava, Balram [3 ]
机构
[1] Indian Council Med Res, Natl Inst Virol, Pune 411021, Maharashtra, India
[2] Bharat Biotech Int Ltd, Genome Valley, Hyderabad 500078, Telangana, India
[3] Indian Council Med Res, V Ramalingaswami Bhawan, POB 4911, New Delhi 110029, India
关键词
SARS-CoV-2; N501Y; escape mutants; vaccine efficacy; neutralization; variant of concern;
D O I
10.1093/jtm/taab051
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
[No abstract available]
引用
收藏
页数:3
相关论文
共 37 条
  • [1] Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin
    Yadav, Pragya D.
    Sapkal, Gajanan N.
    Ella, Raches
    Sahay, Rima R.
    Nyayanit, Dimpal A.
    Patil, Deepak Y.
    Deshpande, Gururaj
    Shete, Anita M.
    Gupta, Nivedita
    Mohan, V. Krishna
    Abraham, Priya
    Panda, Samiran
    Bhargava, Balram
    JOURNAL OF TRAVEL MEDICINE, 2021, 28 (07)
  • [2] SARS-CoV-2 B.1.1.7 variant of concern detected in a pet dog and cat after exposure to a person with COVID-19, USA
    Hamer, Sarah A.
    Ghai, Ria R.
    Zecca, Italo B.
    Auckland, Lisa D.
    Roundy, Christopher M.
    Davila, Edward
    Busselman, Rachel E.
    Tang, Wendy
    Pauvolid-Correa, Alex
    Killian, Mary Lea
    Jenkins-Moore, Melinda
    Torchetti, Mia Kim
    Robbe Austerman, Suelee
    Lim, Ailam
    Akpalu, Yao
    Fischer, Rebecca S. B.
    Barton Behravesh, Casey
    Hamer, Gabriel L.
    TRANSBOUNDARY AND EMERGING DISEASES, 2022, 69 (03) : 1656 - 1658
  • [3] SARS-CoV-2 B.1.1.7 reinfection after previous COVID-19 in two immunocompetent Italian patients
    Novazzi, Federica
    Baj, Andreina
    Genoni, Angelo
    Spezia, Pietro G.
    Colombo, Alberto
    Cassani, Gianluca
    Zago, Cristian
    Pasciuta, Renee
    Della Gasperina, Daniela
    Ageno, Walter
    Severgnini, Paolo
    Dentali, Francesco
    Focosi, Daniele
    Maggi, Fabrizio
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (09) : 5648 - 5649
  • [4] Dynamics of SARS-CoV-2 Alpha (B.1.1.7) variant spread: The wastewater surveillance approach
    Carcereny, Albert
    Garcia-Pedemonte, David
    Martinez-Velazquez, Adan
    Quer, Josep
    Garcia-Cehic, Damir
    Gregori, Josep
    Anton, Andres
    Andres, Cristina
    Pumarola, Tomas
    Chacon-Villanueva, Carme
    Borrego, Carles M.
    Bosch, Albert
    Guix, Susana
    Pinto, Rosa M.
    ENVIRONMENTAL RESEARCH, 2022, 208
  • [5] First Detection of SARS-CoV-2 B.1.1.7 Variant of Concern in an Asymptomatic Dog in Spain
    Barroso-Arevalo, Sandra
    Rivera, Belen
    Dominguez, Lucas
    Sanchez-Vizcaino, Jose M.
    VIRUSES-BASEL, 2021, 13 (07):
  • [6] Clusters of SARS-CoV-2 Lineage B.1.1.7 Infection after Vaccination with Adenovirus-Vectored and Inactivated Vaccines
    de Souza, William M.
    Muraro, Stefanie P.
    Souza, Gabriela F.
    Amorim, Mariene R.
    Sesti-Costa, Renata
    Mofatto, Luciana S.
    Forato, Julia
    Barbosa, Priscilla P.
    Toledo-Teixeira, Daniel A.
    Bispo-dos-Santos, Karina
    Parise, Pierina L.
    Brunetti, Natalia S.
    Moreira, Joselia C. O.
    Costa, Vitor A.
    Cardozo, Daniela M.
    Moretti, Maria L.
    Barros-Mazon, Silvia
    Marchesi, Gabriela F.
    Ambrosio, Christiane
    Spilki, Fernando R.
    Almeida, Valeria C.
    Vieira, Andre S.
    Zambon, Lair
    Farias, Alessandro S.
    Addas-Carvalho, Marcelo
    Benites, Bruno D.
    Marques, Rafael E.
    Sabino, Ester C.
    Von Zuben, Andrea B.
    Weaver, Scott C.
    Faria, Nuno R.
    Granja, Fabiana
    Angerami, Rodrigo N.
    Proenca-Modena, Jose Luiz
    VIRUSES-BASEL, 2021, 13 (11):
  • [7] Neutralization of VUI B.1.1.28 P2 variant with sera of COVID-19 recovered cases and recipients of Covaxin an inactivated COVID-19 vaccine
    Sapkal, Gajanan
    Yadav, Pragya D.
    Ella, Raches
    Abraham, Priya
    Patil, Deepak Y.
    Gupta, Nivedita
    Panda, Samiran
    Mohan, V. Krishna
    Bhargava, Balram
    JOURNAL OF TRAVEL MEDICINE, 2021, 28 (07)
  • [8] FrontierTherapeutics and Vaccine Strategies for SARS-CoV-2 (COVID-19): A Review
    Sheikhshahrokh, Amirhossein
    Ranjbar, Reza
    Saeidi, Elnaz
    Safarpoor Dehkordi, Farhad
    Heiat, Mohammad
    Ghasemi-Dehkordi, Payam
    Goodarzi, Hamed
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2020, 49 : 18 - 29
  • [9] Vaccine against COVID-19 or against SARS-CoV-2 infection?
    Rieske, Piotr
    ALERGOLOGIA POLSKA-POLISH JOURNAL OF ALLERGOLOGY, 2020, 7 (03) : 131 - 145
  • [10] Emergence of B.1.1.318 SARS-CoV-2 viral lineage and high incidence of alpha B.1.1.7 variant of concern in the Republic of Gabon
    Manouana, Gedeon Prince
    Maloum, Moustapha Nzamba
    Bikangui, Rodrigue
    Bingono, Sam O'neilla Oye
    Nguema, Georgelin Ondo
    Honkpehedji, Josiane Yabo
    Rossatanga, Elie Gide
    Zoa-Assoumou, Samira
    Pallerla, Srinivas Reddy
    Rachakonda, Sivaramakrishna
    Mintsa, Armel Ndong
    Lekana-Douki, Jean-Bernard
    Siawaya, Joel-Fleury Djoba
    Borrmann, Steffen
    Kremsner, Peter Gottfried
    Lell, Bertrand
    Velavan, Thirumalaisamy P.
    Adegnika, Ayola Akim
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 114 : 151 - 154